Maryland Juice received the following press announcement indicating that former Maryland Democratic Party Chair Terry Lierman has been appointed as head of the Board of Advisors for the University of Maryland's Institute of Human Virology. Lierman previously ran for Maryland's 8th Congressional District seat and most recently served as Rep. Steny Hoyer's Chief of Staff. See the announcement below:
Press Release
Terry Lierman Appointed Chair of Institute’s Board of Advisors
Brings vast entrepreneurial and political experience to role on board
Baltimore, MD – Dr. Robert C. Gallo, director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, today announced that Mr. Terry Lierman is the new Chair of the Institute’s Board of Advisors. Mr. Lierman is renowned on Capitol Hill for his political skills as well as his passionate support of improved health care and funding for medical research, and was most recently the Chief of Staff to U.S. Rep. Steny Hoyer (D-Md.), currently the Minority Whip of the U.S. House of Representatives.
“Terry has an extraordinary commitment to health care and research, both as an advocate for patients and as the founder of a number of companies and organizations that focus on the advancement of medical science,” said Dr. Robert C. Gallo, who pioneered the field of human retroviruses with his discoveries of HTLV-1 and HTLV-2, co-discovered HIV as the cause of AIDS, and developed the HIV blood test that has saved many thousands of lives. “In addition, Terry has been frequently noted as one of the most influential persons in Washington, DC. I am looking forward to Terry’s contributions to the Board as he applies his terrific leadership skills, vast entrepreneurial and political experience, and broad capabilities for problem-solving and bringing people together.”
IHV is the first center in the United States to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV. The unique structure of the Institute seeks to connect cohesive, multi-disciplinary research and clinical programs so that new treatments are streamlined from discovery to patient. Through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), IHV treats more than 750,000 HIV positive patients in seven African and two Caribbean nations and implements training and prevention programs to develop and enhance PEPFAR countries’ health care infrastructures. Locally, IHV also treats more than 5,000 HIV positive patients in Baltimore while scientific collaborations span the globe. The IHV Board of Advisors, along with the IHV Scientific Advisory Board, provides oversight and guidance to advance the interrelated missions of the Institute.
“I have had the privilege and opportunity to combine politics, policy, and management, and to create a wide variety of ventures to promote better health care,” noted Mr. Lierman. “As the new Chair of the IHV Board of Advisors, I am thrilled to be able to support the exceptional work of Dr. Gallo and the world-class scientific and patient care teams at IHV as they seek breakthrough discoveries in medical science and create new models of patient care.”
Mr. Lierman began his career in the health field at the U.S. National Institutes of Health (NIH) in 1971, where he assisted in budget and policy development, grants, and contracts. Over the last four decades he has combined his entrepreneurial and political talents in a variety of ventures from serving in leadership positions on the staff of the U.S. Senate Appropriations Committee, founding companies and non-profit organizations that advanced health care advocacy, to leading the Maryland Democratic Party. He is currently leading a new venture capital company, Health Ventures International, and chairing CSGI, Inc., the parent company of CTIS, a global health information technology company.
Mr. Lierman replaces former Maryland Lt. Governor Kathleen Kennedy Townsend as the Chair of the IHV Board of Advisors. Ms. Townsend will continue to serve as an active leader on the board.
About Terry Lierman
Terry Lierman began his career in the health field at the National Institutes of Health, where he assisted in budget and policy development, grants, and contracts. He then moved to the U.S. Senate Committee on Appropriations, where he was the Staff Director of the Labor Health and Human Services (HHS) Appropriations Subcommittee as well as the full Committee.
Mr. Lierman founded several companies and organizations, including the Children’s Research Institute at Children’s Hospital National Medical Center, National Coalition for Cancer Research, the National Organization on Fetal Alcohol Syndrome (NOFAS), and the Pancreatic Cancer Action Network (PANCAN). He was the Chair of the Maryland Democratic Party and served as the Chief of Staff to the House of Representatives Majority Leader and Democratic Whip Congressman Steny H. Hoyer.
Mr. Lierman is presently on Venture Capital Boards, President of Energy One, and the Founder of Summit Global Ventures. He now Chairs the Institute of Human Virology, and serves on the Boards of the GVN (Global Virus Network), as well as the Council for a Livable World and Peace PAC.
Brings vast entrepreneurial and political experience to role on board
“Terry has an extraordinary commitment to health care and research, both as an advocate for patients and as the founder of a number of companies and organizations that focus on the advancement of medical science,” said Dr. Robert C. Gallo, who pioneered the field of human retroviruses with his discoveries of HTLV-1 and HTLV-2, co-discovered HIV as the cause of AIDS, and developed the HIV blood test that has saved many thousands of lives. “In addition, Terry has been frequently noted as one of the most influential persons in Washington, DC. I am looking forward to Terry’s contributions to the Board as he applies his terrific leadership skills, vast entrepreneurial and political experience, and broad capabilities for problem-solving and bringing people together.”
IHV is the first center in the United States to combine the disciplines of basic science, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably HIV. The unique structure of the Institute seeks to connect cohesive, multi-disciplinary research and clinical programs so that new treatments are streamlined from discovery to patient. Through the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), IHV treats more than 750,000 HIV positive patients in seven African and two Caribbean nations and implements training and prevention programs to develop and enhance PEPFAR countries’ health care infrastructures. Locally, IHV also treats more than 5,000 HIV positive patients in Baltimore while scientific collaborations span the globe. The IHV Board of Advisors, along with the IHV Scientific Advisory Board, provides oversight and guidance to advance the interrelated missions of the Institute.
“I have had the privilege and opportunity to combine politics, policy, and management, and to create a wide variety of ventures to promote better health care,” noted Mr. Lierman. “As the new Chair of the IHV Board of Advisors, I am thrilled to be able to support the exceptional work of Dr. Gallo and the world-class scientific and patient care teams at IHV as they seek breakthrough discoveries in medical science and create new models of patient care.”
Mr. Lierman began his career in the health field at the U.S. National Institutes of Health (NIH) in 1971, where he assisted in budget and policy development, grants, and contracts. Over the last four decades he has combined his entrepreneurial and political talents in a variety of ventures from serving in leadership positions on the staff of the U.S. Senate Appropriations Committee, founding companies and non-profit organizations that advanced health care advocacy, to leading the Maryland Democratic Party. He is currently leading a new venture capital company, Health Ventures International, and chairing CSGI, Inc., the parent company of CTIS, a global health information technology company.
Mr. Lierman replaces former Maryland Lt. Governor Kathleen Kennedy Townsend as the Chair of the IHV Board of Advisors. Ms. Townsend will continue to serve as an active leader on the board.
About Terry Lierman
Terry Lierman began his career in the health field at the National Institutes of Health, where he assisted in budget and policy development, grants, and contracts. He then moved to the U.S. Senate Committee on Appropriations, where he was the Staff Director of the Labor Health and Human Services (HHS) Appropriations Subcommittee as well as the full Committee.
Mr. Lierman founded several companies and organizations, including the Children’s Research Institute at Children’s Hospital National Medical Center, National Coalition for Cancer Research, the National Organization on Fetal Alcohol Syndrome (NOFAS), and the Pancreatic Cancer Action Network (PANCAN). He was the Chair of the Maryland Democratic Party and served as the Chief of Staff to the House of Representatives Majority Leader and Democratic Whip Congressman Steny H. Hoyer.
Mr. Lierman is presently on Venture Capital Boards, President of Energy One, and the Founder of Summit Global Ventures. He now Chairs the Institute of Human Virology, and serves on the Boards of the GVN (Global Virus Network), as well as the Council for a Livable World and Peace PAC.
###
No comments:
Post a Comment